Teva Pharmaceutical Industries Limited (TLV:TEVA)

TLV:TEVA Ratios and Metrics

Market cap in millions ILS. Fiscal year is January - December.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 4, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	127,555	114,152	91,081	42,146	35,617	27,480
Market Cap Growth	76.50%	25.33%	116.11%	18.33%	29.61%	-19.18%
Enterprise Value	167,423	161,627	150,359	109,242	106,456	99,359
Last Close Price	109.10	100.90	81.01	38.15	32.99	26.95

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 4, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	60.65	25.40	-	-	-	21.19
PS Ratio	2.47	2.08	1.51	0.74	0.68	0.56
PB Ratio	5.52	4.52	4.37	1.44	1.18	0.79
P/FCF Ratio	31.79	31.19	33.39	13.90	9.72	37.44
P/OCF Ratio	22.56	21.71	20.05	8.56	6.37	11.07

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 4, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
EV/Sales Ratio	3.21	2.94	2.50	1.91	2.03	2.01
EV/EBITDA Ratio	12.60	10.23	9.31	6.99	7.63	7.25
EV/EBIT Ratio	16.89	12.83	12.24	9.52	11.37	10.38
EV/FCF Ratio	41.72	44.16	55.12	36.03	29.06	135.36

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 4, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Debt / Equity Ratio	2.18	2.18	3.18	2.50	2.52	2.10
Debt / EBITDA Ratio	3.84	3.39	3.98	4.53	5.26	5.19
Debt / FCF Ratio	12.54	15.01	24.28	24.08	20.80	99.97
Net Debt / Equity Ratio	1.71	1.73	2.60	2.10	2.19	1.91
Net Debt / EBITDA Ratio	3.10	2.76	3.36	3.93	4.75	4.86
Net Debt / FCF Ratio	9.83	11.91	19.87	20.25	18.11	90.80
Asset Turnover	0.43	0.43	0.40	0.36	0.33	0.32
Inventory Turnover	2.45	2.69	2.41	2.09	2.08	2.02
Quick Ratio	0.46	0.54	0.50	0.54	0.57	0.61
Current Ratio	0.88	1.04	0.98	1.02	1.05	1.14
Return on Equity (ROE)	9.69%	20.79%	-28.30%	-7.36%	-25.19%	4.09%
Return on Assets (ROA)	5.13%	6.17%	5.09%	4.55%	3.63%	3.91%
Return on Invested Capital (ROIC)	15.21%	18.73%	14.74%	12.10%	8.85%	6.18%
Return on Capital Employed (ROCE)	13.50%	14.50%	12.70%	10.20%	8.20%	8.40%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 4, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Earnings Yield	1.65%	3.94%	-6.55%	-4.78%	-24.15%	4.72%
FCF Yield	3.15%	3.21%	3.00%	7.20%	10.29%	2.67%
Buyback Yield / Dilution	-2.24%	-2.83%	-1.07%	-0.81%	-0.27%	-1.10%
Total Shareholder Return	-2.24%	-2.83%	-1.07%	-0.81%	-0.27%	-1.10%

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 4, 2026

Data Sources Report a data error